Πλοήγηση ανά Συγγραφέα "Berger, T. J."
-
Is Botulinum Neurotoxin Type A (BoNT-A) a Novel Therapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement? A Review of the Literature
Oeconomou, A.; Madersbacher, H.; Kiss, G.; Berger, T. J.; Melekos, M.; Rehder, P. (2008)Context: The intraprostatic injection of botulinum neurotoxin type A (BoNT-A) is a minimally invasive but still-experimental treatment of lower urinary tract symptoms (LUTS) due to benign prostatic enlargment (BPE) based ... -
Is Botulinum Neurotoxin Type A (BoNT-A) a Novel Therapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement? A Review of the Literature Editorial Comment
Oeconomou, A.; Madersbacher, H.; Kiss, G.; Berger, T. J.; Melekos, M.; Rehder, P. (2009)